Analysis of the reasons for accepting or declining participation in genetic research for breast cancer

A hospital-based population study

Angelo Paradiso, Michele Bruno, Onofrio Cicoria, Maria Digennaro, Salvafore Longo, Michele Rinaldi, Francesco Schittulli

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The majority of a hospital-based population accepted to participate in a molecular screening project for familial breast cancer, giving their informed consent to blood sampling. Only 9.5% of patients declined to sign the consent form. Here we report the reasons for refusal and we critically review our methodological approach to obtain consent for a blood test for genetic research in a clinical setting.

Original languageEnglish
Pages (from-to)435-436
Number of pages2
JournalTumori
Volume90
Issue number4
Publication statusPublished - Jul 2004

Fingerprint

Consent Forms
Cancer Care Facilities
Genetic Research
Hematologic Tests
Informed Consent
Breast Neoplasms
Population
Familial Breast Cancer

Keywords

  • Breast cancer risk
  • Genetic research
  • Hospital-based population
  • Informed consent

ASJC Scopus subject areas

  • Cancer Research

Cite this

Paradiso, A., Bruno, M., Cicoria, O., Digennaro, M., Longo, S., Rinaldi, M., & Schittulli, F. (2004). Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: A hospital-based population study. Tumori, 90(4), 435-436.

Analysis of the reasons for accepting or declining participation in genetic research for breast cancer : A hospital-based population study. / Paradiso, Angelo; Bruno, Michele; Cicoria, Onofrio; Digennaro, Maria; Longo, Salvafore; Rinaldi, Michele; Schittulli, Francesco.

In: Tumori, Vol. 90, No. 4, 07.2004, p. 435-436.

Research output: Contribution to journalArticle

Paradiso, A, Bruno, M, Cicoria, O, Digennaro, M, Longo, S, Rinaldi, M & Schittulli, F 2004, 'Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: A hospital-based population study', Tumori, vol. 90, no. 4, pp. 435-436.
Paradiso, Angelo ; Bruno, Michele ; Cicoria, Onofrio ; Digennaro, Maria ; Longo, Salvafore ; Rinaldi, Michele ; Schittulli, Francesco. / Analysis of the reasons for accepting or declining participation in genetic research for breast cancer : A hospital-based population study. In: Tumori. 2004 ; Vol. 90, No. 4. pp. 435-436.
@article{6f361ba313914844aea9f11fe1fdd579,
title = "Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: A hospital-based population study",
abstract = "The majority of a hospital-based population accepted to participate in a molecular screening project for familial breast cancer, giving their informed consent to blood sampling. Only 9.5{\%} of patients declined to sign the consent form. Here we report the reasons for refusal and we critically review our methodological approach to obtain consent for a blood test for genetic research in a clinical setting.",
keywords = "Breast cancer risk, Genetic research, Hospital-based population, Informed consent",
author = "Angelo Paradiso and Michele Bruno and Onofrio Cicoria and Maria Digennaro and Salvafore Longo and Michele Rinaldi and Francesco Schittulli",
year = "2004",
month = "7",
language = "English",
volume = "90",
pages = "435--436",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Analysis of the reasons for accepting or declining participation in genetic research for breast cancer

T2 - A hospital-based population study

AU - Paradiso, Angelo

AU - Bruno, Michele

AU - Cicoria, Onofrio

AU - Digennaro, Maria

AU - Longo, Salvafore

AU - Rinaldi, Michele

AU - Schittulli, Francesco

PY - 2004/7

Y1 - 2004/7

N2 - The majority of a hospital-based population accepted to participate in a molecular screening project for familial breast cancer, giving their informed consent to blood sampling. Only 9.5% of patients declined to sign the consent form. Here we report the reasons for refusal and we critically review our methodological approach to obtain consent for a blood test for genetic research in a clinical setting.

AB - The majority of a hospital-based population accepted to participate in a molecular screening project for familial breast cancer, giving their informed consent to blood sampling. Only 9.5% of patients declined to sign the consent form. Here we report the reasons for refusal and we critically review our methodological approach to obtain consent for a blood test for genetic research in a clinical setting.

KW - Breast cancer risk

KW - Genetic research

KW - Hospital-based population

KW - Informed consent

UR - http://www.scopus.com/inward/record.url?scp=4444380280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444380280&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 435

EP - 436

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4

ER -